Table 1.
Susceptibility of tested Candida isolates to conventional antimitotic agents. S—susceptible; R—resistance; I—intermediate; AMB—Amphotericin B; FLU—Fluconazole; VOR—Voriconazole; CSF–Caspofungin; MCF–Micafungin; FC–Flucytosine; “-“—no breakpoints.
| Fungal Strain | Antimycotic Susceptibility ([μg/mL]/Interpretation) | |||||
|---|---|---|---|---|---|---|
| AMB | FLU | VOR | CSF | MCF | FC | |
| C. albicans 138 | 0.25/S | 0.5/S | 0.12/S | 0.12/S | 0.06/S | 1/S |
| C. albicans 166 | 0.5/S | 0.5/S | 0.12/S | 0.12/S | 0.06/S | 1/S |
| C. albicans 177 | 1/S | 0.5/S | 0.12/S | 0.12/S | 0.06/S | 1/S |
| C. albicans 185 | 0.25/S | 0.5/S | 0.12/S | 0.12/S | 0.06/S | 1/S |
| C. albicans 197 | 0.5/S | 0.5/S | 0.12/S | 0.12/S | 0.06/S | 1/S |
| C. albicans 1408 | 1/S | 1/S | 0.12/S | 0.12/S | 0.06/S | 1/S |
| C. albicans ATCC 26790 | 1/S | 0.5/S | 0.12/S | 0.12/S | 0.06/S | 1/S |
| C. glabrata 132 | 1/S | -/R | 0.25/I | 0.25/I | 0.06/S | 1/S |
| C. glabrata 145 | 1/S | -/R | 0.25/I | 0.25/I | 0.06/S | 1/S |
| C. glabrata 154 | 0.5/S | -/R | 0.12/S | 0.25/I | 0.06/S | 1/S |
| C. krusei 137 | 0.5/S | -/R | 0.12/S | 0.5/I | 0.12/S | 16/I |
| C. krusei 148 | 0.5/S | -/R | 0.12/S | 0.5/S | 0.12/S | 16/I |
| C. krusei 156 | 0.5/S | -R | 0.12/S | 0.5/I | 0.12/S | 16/I |
| C. krusei 163 | 0.5/S | -/R | 0.12/S | 0.5/I | 0.12/S | 16/I |
| C. krusei 176 | 0.5/S | -/R | 0.12/S | 0.5/I | 0.12/S | 16/I |
| C. krusei 184 | 0.5/S | -/R | 0.12/S | 0.5/I | 0.12/S | 16/I |
| C. tropicalis 133 | 0.25/S | 0.5/S | 0.12/S | 0.12/S | 0.06/S | 1/S |
| C. tropicalis 157 | 0.5/S | 1/S | 0.12/S | 0.12/S | 0.06/S | 1/S |
| C. tropicalis 165 | 0.25/S | 1/S | 0.12/S | 0.12/S | 0.06/S | 1/S |
| C. tropicalis 178 | 0.5/S | 0.5/S | 0.12/S | 0.12/S | 0.06/S | 1/S |
| C. tropicalis 191 | 0.25/S | 0.5/S | 0.12/S | 0.12/S | 0.06/S | 1/S |